ABU FARHAN, ABDAL RAHMAN
 Distribuzione geografica
Continente #
NA - Nord America 138
EU - Europa 59
AS - Asia 31
SA - Sud America 1
Totale 229
Nazione #
US - Stati Uniti d'America 133
IT - Italia 24
SG - Singapore 16
GB - Regno Unito 12
CN - Cina 10
SE - Svezia 10
FR - Francia 9
CA - Canada 5
DE - Germania 3
IN - India 2
JP - Giappone 2
BR - Brasile 1
FI - Finlandia 1
VN - Vietnam 1
Totale 229
Città #
Chandler 45
London 10
West Jordan 10
Bagneux 8
Singapore 7
Santa Clara 6
Ashburn 5
Chicago 5
Milan 5
Princeton 5
Lawrence 4
Ottawa 4
Rome 4
Wilmington 3
Bordighera 2
Des Moines 2
Ferrara 2
Los Angeles 2
Mendicino 2
Rui'an 2
Tokyo 2
Augusta 1
Beijing 1
Boa Vista da Aparecida 1
Boardman 1
Catania 1
Catanzaro 1
Charlotte 1
Cleveland 1
Foggia 1
Hanoi 1
Hanover 1
Harbin 1
Montreal 1
Mumbai 1
Munich 1
Pune 1
Redmond 1
Secaucus 1
Serra D'aiello 1
Shanghai 1
Shenzhen 1
The Dalles 1
Turku 1
Wigan 1
Totale 159
Nome #
Association of statin use and oncological outcomes in patients with first diagnosis of T1 high grade non-muscle invasive urothelial bladder cancer: results from a multicentre study 60
Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor 58
Neutrophil percentage-to-albumin ratio predicts mortality in bladder cancer patients treated with neoadjuvant chemotherapy followed by radical cystectomy 47
A risk-group classification model in patients with bladder cancer under neoadjuvant cisplatin-based combination chemotherapy 45
Systemic combining inflammatory score (SCIS): a new score for prediction of oncologic outcomes in patients with high-risk non-muscle-invasive urothelial bladder cancer 42
Totale 252
Categoria #
all - tutte 2.573
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.573


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202112 0 0 0 1 0 0 3 1 6 1 0 0
2021/202246 2 0 2 20 0 0 8 7 0 0 4 3
2022/202382 9 7 3 8 13 9 7 7 12 3 4 0
2023/202443 1 7 2 6 4 13 0 0 0 10 0 0
2024/202560 8 11 1 1 3 6 1 5 9 0 7 8
Totale 252